Alemtuzumab (Campath-1H) in allogeneic stem cell transplantation: where do we go from here?

Alemtuzumab (Campath-1H) in allogeneic stem cell transplantation: where do we go from here?

Alemtuzumab (Campath-1H) has been widely used for T-cell depletion following both conventional and reduced-intensity conditioning allografts. We studied the impact of alemtuzumab used in vivo and in vitro on infections, immune reconstitution, and allograft outcome. The use of alemtuzumab in vivo fol...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй
Үндсэн зохиолчид:	Chakrabarti, S, Hale, G, Waldmann, H
Формат:	Journal article
Хэл сонгох:	English
Хэвлэсэн:	2004

Ижил төстэй зүйлс

Campath 1H (alemtuzumab) in renal transplantation: 5-year comparative follow up.
-н: Watson, C, зэрэг
Хэвлэсэн: (2004)

Alemtuzumab (Campath-1H) for treatment of lymphoid malignancies in the age of nonmyeloablative conditioning?
-н: Hale, G, зэрэг
Хэвлэсэн: (2002)

The evolving role of alemtuzumab (Campath-1H) in renal transplantation
-н: Phuong-Thu T Pham, зэрэг
Хэвлэсэн: (2008-12-01)

T cell depletion with CAMPATH-1 in allogeneic bone marrow transplantation.
-н: Hale, G, зэрэг
Хэвлэсэн: (1988)

Alemtuzumab (CAMPATH-1H) for the treatment of acute rejection in kidney transplant recipients: long-term follow-up.
-н: Clatworthy, MR, зэрэг
Хэвлэсэн: (2009)

Alemtuzumab (CAMPATH 1H) induction therapy in cadaveric kidney transplantation--efficacy and safety at five years.
-н: Watson, C, зэрэг
Хэвлэсэн: (2005)

Campath 1 H "in the bag" is an effective method of GvHD prevention in allogeneic stem cell transplantation.
-н: Potter, M, зэрэг
Хэвлэсэн: (2000)

Allogeneic hematopoietic stem cell transplantation in China: where we are and where to go
-н: Lv Meng, зэрэг
Хэвлэсэн: (2012-03-01)

COMBINED USE OF CAMPATH-1G IN-VIVO AND IN THE BAG IN ALLOGENEIC BONE-MARROW TRANSPLANTATION
-н: Fibbe, W, зэрэг
Хэвлэсэн: (1993)

CAMPATH-1 antibodies in stem-cell transplantation.
-н: Hale, G, зэрэг
Хэвлэсэн: (2001)

Where do we go from here?
-н: Rai, Vijesh
Хэвлэсэн: (2016)

Expert Systems: Where Are We? And Where Do We Go from Here?
-н: Davis, зэрэг
Хэвлэсэн: (2004)

Editorial: Where Are We Now and Where Do We Go From Here
-н: Gabriele Manganaro
Хэвлэсэн: (2022-01-01)

Availability of Campath-1 antibodies for bone marrow transplantation.
-н: Hale, G, зэрэг
Хэвлэсэн: (1995)

CAMPATH-1 monoclonal antibodies in bone marrow transplantation.
-н: Hale, G, зэрэг
Хэвлэсэн: (1994)

Alemtuzumab (Campath-1H) para tratamento da leucemia linfóide crônica
-н: Maria Kadma da Silva Carriço, зэрэг
Хэвлэсэн: (2003-06-01)

Tractography: where do we go from here?
-н: Jbabdi, S, зэрэг
Хэвлэсэн: (2011)

Afterword: Where Do We Go from Here?
-н: Kimberly Vinall, зэрэг
Хэвлэсэн: (2017-01-01)

Transplantation tolerance: the big picture. Where do we stand, where should we go?
-н: Waldmann, H
Хэвлэсэн: (2017)

Allogeneic stem cell transplantation for lymphoproliferative disease using BEAM-Campath conditioning: An effective regime with low procedure-related toxicity.
-н: Cull, G, зэрэг
Хэвлэсэн: (1999)

Commentary: Retinoblastoma management–Where are we and where do we go from here?
-н: P Mahesh Shanmugam
Хэвлэсэн: (2020-01-01)

Phase II study of subcutaneous alemtuzumab (Campath-1H) therapy of patients with previously untreated chronic lymphocytic leukemia (CLL).
-н: Lundin, J, зэрэг
Хэвлэсэн: (2001)

How Did We Get Here and Where are We Going?
-н: Georgina CHAMBERS
Хэвлэсэн: (2022-09-01)

Evaluation of non-myeloablative conditioning combining beam with in vivo pre-transplant Campath-IG for allogeneic transplantation in patients with lymphoma.
-н: Russell, N, зэрэг
Хэвлэсэн: (1999)

CAMPATH-1H in inflammatory arthritis.
-н: Watts, R, зэрэг
Хэвлэсэн: (1993)

COVID-19 - where do we go from here?
-н: Lee, Pei Hua, зэрэг
Хэвлэсэн: (2020)

Propriospinal myoclonus: where do we go from here?
-н: Brown, P
Хэвлэсэн: (2014)

Oil prices : where do we go from here?/
-н: 284295 Zanoyan, Vahan
Хэвлэсэн: (1986)

Math anxiety : where do we go from here? /
-н: 297422 Hunt, Glen E.

Advanced ceramics : where do we go from here?/
-н: 348668 Smith, Vincent, зэрэг

Multiple Sclerosis: Where do we go from here?
-н: Marta Tejera-Alhambra, зэрэг
Хэвлэсэн: (2016-07-01)

Calibration research: Where do we go from here?
-н: Linda eBol, зэрэг
Хэвлэсэн: (2012-07-01)

PITUITARY INCIDENTALOMAS – WHERE DO WE GO FROM HERE?
-н: Syed Ali Imran
Хэвлэсэн: (2016-08-01)

Developmental Dyslexia: Where Do We Go from Here?
-н: Paul E. Engelhardt
Хэвлэсэн: (2020-03-01)

OMR At Crossroads; Where Do We Go From Here ?
-н: Mangala Meti
Хэвлэсэн: (2004-01-01)

Topological photonics: Where do we go from here?
-н: Segev Mordechai, зэрэг
Хэвлэсэн: (2020-10-01)

T-cell depletion with Campath-1H "in the bag" for matched related allogeneic peripheral blood stem cell transplantation is associated with reduced graft-versus-host disease, rapid immune constitution and improved survival.
-н: Chakrabarti, S, зэрэг
Хэвлэсэн: (2003)

In vivo CAMPATH-1H prevents GvHD following nonmyeloablative stem-cell transplantation.
-н: Kottaridis, P, зэрэг
Хэвлэсэн: (2001)

CAMPATH: from concept to clinic.
-н: Waldmann, H, зэрэг
Хэвлэсэн: (2005)

Preliminary experience of allogeneic stem cell transplantation for lymphoproliferative disorders using BEAM-CAMPATH conditioning: an effective regimen with low procedure-related toxicity.
-н: Cull, G, зэрэг
Хэвлэсэн: (2000)